Korla Longzhiyuan Pharmaceutical

Korla Longzhiyuan Pharmaceutical is a specialized pharmaceutical company based in the Xinjiang Uygur Autonomous Region of China, focusing on the industrialization of traditional Uyghur medicine. The company is primarily recognized for its research, development, and production of ethnic medicinal preparations targeting chronic skin conditions, most notably vitiligo. Its flagship product, Zulipikaer Capsules, is a widely utilized treatment in Chinese dermatology for pigmentary disorders. Operating from a GMP-certified facility in Korla, the company leverages local botanical resources to produce a variety of dosage forms including capsules, tablets, and tinctures. Longzhiyuan plays a key role in the regional healthcare economy by modernizing traditional ethnic prescriptions for broader clinical use.